Search

Shobha Kantamneni

Examiner (ID: 1732, Phone: (571)272-2930 , Office: P/1627 )

Most Active Art Unit
1627
Art Unit(s)
1627, 1617, 1623
Total Applications
1212
Issued Applications
306
Pending Applications
120
Abandoned Applications
793

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6638819 [patent_doc_number] => 20100036001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'HEPAROSAN POLYMERS AND METHODS OF MAKING AND USING SAME FOR THE ENHANCEMENT OF THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 12/556324 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15897 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20100036001.pdf [firstpage_image] =>[orig_patent_app_number] => 12556324 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/556324
Heparosan polymers and methods of making and using same for the enhancement of therapeutics Sep 8, 2009 Issued
Array ( [id] => 6496170 [patent_doc_number] => 20100093865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/553054 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 108630 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093865.pdf [firstpage_image] =>[orig_patent_app_number] => 12553054 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/553054
SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS Sep 1, 2009 Abandoned
Array ( [id] => 6376085 [patent_doc_number] => 20100076089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'ANTIMICROBIAL GEL FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/540251 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15586 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076089.pdf [firstpage_image] =>[orig_patent_app_number] => 12540251 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/540251
ANTIMICROBIAL GEL FORMULATIONS Aug 11, 2009 Abandoned
Array ( [id] => 5304210 [patent_doc_number] => 20090298862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition' [patent_app_type] => utility [patent_app_number] => 12/315740 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 33263 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298862.pdf [firstpage_image] =>[orig_patent_app_number] => 12315740 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/315740
Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition Aug 6, 2009 Abandoned
Array ( [id] => 5973326 [patent_doc_number] => 20110152377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'EXTERNAL PREPARATION COMPRISING FATTY ACID SALT OR BENZOIC ACID SALT OF BASIC PHARMACOLOGICALLY ACTIVE COMPONENT, AND METHOD FOR PRODUCTION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/057188 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13669 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152377.pdf [firstpage_image] =>[orig_patent_app_number] => 13057188 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/057188
EXTERNAL PREPARATION COMPRISING FATTY ACID SALT OR BENZOIC ACID SALT OF BASIC PHARMACOLOGICALLY ACTIVE COMPONENT, AND METHOD FOR PRODUCTION THEREOF Aug 2, 2009 Abandoned
Array ( [id] => 7657342 [patent_doc_number] => 20110306611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Transcription factor modulating compounds and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/462405 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 58053 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306611.pdf [firstpage_image] =>[orig_patent_app_number] => 12462405 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/462405
Transcription factor modulating compounds and methods of use thereof Aug 2, 2009 Issued
Array ( [id] => 6257930 [patent_doc_number] => 20100029755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'P-Glycoprotein inhibitor comprising octilonium bromide as an effective ingredient' [patent_app_type] => utility [patent_app_number] => 12/458673 [patent_app_country] => US [patent_app_date] => 2009-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4996 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029755.pdf [firstpage_image] =>[orig_patent_app_number] => 12458673 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/458673
P-Glycoprotein inhibitor comprising octilonium bromide as an effective ingredient Jul 19, 2009 Abandoned
Array ( [id] => 5959685 [patent_doc_number] => 20110184072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'FORMULATION INTENDED TO IMPROVING THE BIOAVAILABILITY OF A HYDROPHOBIC MOLECULE' [patent_app_type] => utility [patent_app_number] => 13/054776 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2620 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20110184072.pdf [firstpage_image] =>[orig_patent_app_number] => 13054776 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/054776
FORMULATION INTENDED TO IMPROVING THE BIOAVAILABILITY OF A HYDROPHOBIC MOLECULE Jul 15, 2009 Abandoned
Array ( [id] => 6496260 [patent_doc_number] => 20100010062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'METHOD OF TREATMENT USING EPROSARTAN' [patent_app_type] => utility [patent_app_number] => 12/500425 [patent_app_country] => US [patent_app_date] => 2009-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11220 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010062.pdf [firstpage_image] =>[orig_patent_app_number] => 12500425 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/500425
METHOD OF TREATMENT USING EPROSARTAN Jul 8, 2009 Abandoned
Array ( [id] => 6033352 [patent_doc_number] => 20110082161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'POWDERS FOR RECONSTITUTION' [patent_app_type] => utility [patent_app_number] => 12/997185 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9200 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082161.pdf [firstpage_image] =>[orig_patent_app_number] => 12997185 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/997185
POWDERS FOR RECONSTITUTION Jun 29, 2009 Abandoned
Array ( [id] => 6039508 [patent_doc_number] => 20110092557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Neuraminidase Inhibitors And Compositions And Methods Related Thereto' [patent_app_type] => utility [patent_app_number] => 12/490650 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8871 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092557.pdf [firstpage_image] =>[orig_patent_app_number] => 12490650 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/490650
Neuraminidase Inhibitors And Compositions And Methods Related Thereto Jun 23, 2009 Abandoned
Array ( [id] => 6048863 [patent_doc_number] => 20110207834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'HIGHLY PURIFIED POLYLACTIC ACID OR A DERIVATIVE THEREOF, A SALT OF THE SAME, AND PURIFICATION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 13/126395 [patent_app_country] => US [patent_app_date] => 2009-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5253 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207834.pdf [firstpage_image] =>[orig_patent_app_number] => 13126395 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/126395
Highly purified polylactic acid or a derivative thereof, a salt of the same, and purification method thereof Jun 22, 2009 Issued
Array ( [id] => 7490764 [patent_doc_number] => 20110237677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/997424 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5114 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237677.pdf [firstpage_image] =>[orig_patent_app_number] => 12997424 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/997424
Inhibitors Jun 9, 2009 Abandoned
Array ( [id] => 5987447 [patent_doc_number] => 20110098366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Pharmaceutical Preparation in Containers that are Pervious to Water Vapor and Have Improved Stability' [patent_app_type] => utility [patent_app_number] => 12/997909 [patent_app_country] => US [patent_app_date] => 2009-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1981 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098366.pdf [firstpage_image] =>[orig_patent_app_number] => 12997909 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/997909
Pharmaceutical Preparation in Containers that are Pervious to Water Vapor and Have Improved Stability May 29, 2009 Abandoned
Array ( [id] => 9850346 [patent_doc_number] => 08952075 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-10 [patent_title] => 'Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions' [patent_app_type] => utility [patent_app_number] => 12/454774 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3500 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12454774 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/454774
Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions May 21, 2009 Issued
Array ( [id] => 5514168 [patent_doc_number] => 20090214474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development' [patent_app_type] => utility [patent_app_number] => 12/387239 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58312 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214474.pdf [firstpage_image] =>[orig_patent_app_number] => 12387239 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/387239
Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development Apr 29, 2009 Abandoned
Array ( [id] => 8174226 [patent_doc_number] => 20120108823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'ANTI-FRANCISELLA AGENTS' [patent_app_type] => utility [patent_app_number] => 12/428035 [patent_app_country] => US [patent_app_date] => 2009-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9295 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108823.pdf [firstpage_image] =>[orig_patent_app_number] => 12428035 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/428035
ANTI-FRANCISELLA AGENTS Apr 21, 2009 Abandoned
Array ( [id] => 5302946 [patent_doc_number] => 20090297598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'THERAPEUTIC COMBINATION' [patent_app_type] => utility [patent_app_number] => 12/427420 [patent_app_country] => US [patent_app_date] => 2009-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11286 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297598.pdf [firstpage_image] =>[orig_patent_app_number] => 12427420 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/427420
THERAPEUTIC COMBINATION Apr 20, 2009 Abandoned
Array ( [id] => 10830847 [patent_doc_number] => 08859009 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Method of fixing antibacterial agent and article obtained by the method' [patent_app_type] => utility [patent_app_number] => 12/736794 [patent_app_country] => US [patent_app_date] => 2009-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 9147 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12736794 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/736794
Method of fixing antibacterial agent and article obtained by the method Apr 20, 2009 Issued
Array ( [id] => 5570421 [patent_doc_number] => 20090253799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'DIVALENT HYDRAZIDE COMPOUND CONJUGATES FOR INHIBITING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR' [patent_app_type] => utility [patent_app_number] => 12/418147 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 31139 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253799.pdf [firstpage_image] =>[orig_patent_app_number] => 12418147 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/418147
DIVALENT HYDRAZIDE COMPOUND CONJUGATES FOR INHIBITING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Apr 2, 2009 Abandoned
Menu